Search Results - "Mayer, E. L"

SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer by Mayer, E.L., Dhakil, S., Patel, T., Sundaram, S., Fabian, C., Kozloff, M., Qamar, R., Volterra, F., Parmar, H., Samant, M., Burstein, H.J.

“…The vascular endothelial growth factor (VEGF) pathway can be targeted through VEGF neutralization or VEGF receptor (VEGFR) blockade using tyrosine kinase…”
Get full text

Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer by Mayer, E. L, Partridge, A. H, Harris, L. N, Gelman, R. S, Schumer, S. T, Burstein, H. J, Winer, E. P

“…Purpose: This phase I study explored gefitinib (G) and capecitabine (C) in metastatic breast cancer (MBC). Methods: Sequential cohorts (n = 3) received G and…”
Get full text

A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer by Lin, N. U., Seah, D. S., Gelman, R., Desantis, S., Mayer, E. L., Isakoff, S., DiPiro, P., Krop, I. E., Come, S. E., Weckstein, D., Winer, E. P., Burstein, H. J.

“…We aimed to evaluate the efficacy and feasibility of combining trastuzumab/vinorelbine with bevacizumab in patients with first-or second-line HER2-positive,…”
Get full text

Is there a role for continuation of CDK4/6 inhibition after progression on a prior CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer? by Giordano, A, Lin, N U, Tolaney, S M, Mayer, E L

Get more information

Homocysteine and coronary atherosclerosis by Mayer, Ellen L., Jacobsen, Donald W., Robinson, Killian

“…Homocysteine is increasingly recognized as a risk factor for coronary artery disease. An understanding of its metabolism and of the importance of vitamins…”
Get full text

TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker by Mayer, E.L., Abramson, V., Jankowitz, R., Falkson, C., Marcom, P.K., Traina, T., Carey, L., Rimawi, M., Specht, J., Miller, K., Stearns, V., Tung, N., Perou, C., Richardson, A.L., Componeschi, K., Trippa, L., Tan-Wasielewski, Z., Timms, K., Krop, I., Wolff, A.C., Winer, E.P.

“…Cisplatin and paclitaxel are active in triple-negative breast cancer (TNBC). Despite different mechanisms of action, effective predictive biomarkers to…”
Get full text

Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL by Shivdasani, Ramesh A, Mayer, Erica L, Orkin, Stuart H

“…Chromosomal translocations associated with malignancies often result in deregulated expression of genes encoding transcription factors. In human T-cell…”
Get full text

Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations by ROBINSON, K, GUPTA, A, JACOBSEN, D. W, DENNIS, V, ARHEART, K, CHAUDHARY, D, GREEN, R, VIGO, P, MAYER, E. L, SELHUB, J, KUTNER, M

“…A high level of total plasma homocysteine is a risk factor for atherosclerosis, which is an important cause of death in renal failure. We evaluated the role of…”
Get full text

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030 by Parsons, H.A., Blewett, T., Chu, X., Sridhar, S., Santos, K., Xiong, K., Abramson, V.G., Patel, A., Cheng, J., Brufsky, A., Rhoades, J., Force, J., Liu, R., Traina, T.A., Carey, L.A., Rimawi, M.F., Miller, K.D., Stearns, V., Specht, J., Falkson, C., Burstein, H.J., Wolff, A.C., Winer, E.P., Tayob, N., Krop, I.E., Makrigiorgos, G.M., Golub, T.R., Mayer, E.L., Adalsteinsson, V.A.

“…We aimed to examine circulating tumor DNA (ctDNA) and its association with residual cancer burden (RCB) using an ultrasensitive assay in patients with…”
Get full text

A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma by Mayer, E.L., DeMichele, A., Rugo, H.S., Miller, K., Waks, A.G., Come, S.E., Mulvey, T., Jeselsohn, R., Overmoyer, B., Guo, H., Barry, W.T., Huang Bartlett, C., Koehler, M., Winer, E.P., Burstein, H.J.

“…The CDK4/6 inhibitor palbociclib prolongs progression-free survival in hormone receptor-positive/HER2-negative (HR+/HER2−) metastatic breast cancer when…”
Get full text

Subjectivity and intersubjectivity of clinical facts by Mayer, E L

“…The author has learned a great deal from the IJPA 75th Anniversary Issue, particularly regarding ways in which psychoanalysts across the world are consensually…”
Get more information

'Everybody must be just like me': observations on female castration anxiety by Mayer, E L

“…The concept of primary femininity entails an assumption that the girl develops some mental representation of genital femaleness at an early age. I have…”
Get more information

Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease by Robinson, K, Mayer, E L, Miller, D P, Green, R, van Lente, F, Gupta, A, Kottke-Marchant, K, Savon, S R, Selhub, J, Nissen, S E

“…High plasma homocysteine is associated with premature coronary artery disease in men, but the threshold concentration defining this risk and its importance in…”
Get full text

Some implications for psychoanalytic technique drawn from analysis of a dying patient by Mayer, E L

“…The analysis of a dying patient is presented. The suggestion is made that analytic work with people who are dying is both possible and productive. The unusual…”
Get more information

On “Telepathic Dreams?”: An Unpublished Paper by Robert J. Stoller by Mayer, Elizabeth, Lloyd

“…In 1973 Robert Stoller wrote a paper on a series of dreams—his own and his patients'—that he reluctantly found himself calling `telepathic.` He never submitted…”
Get full text

Incorporating immunotherapy in the management of early-stage estrogen receptor-positive breast cancer by Nader-Marta, G., Waks, A.G., Tolaney, S.M., Mayer, E.L.

Get full text

Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch by NEUTRA, M. R, PHILLIPS, T. L, MAYER, E. L, FISHKIND, D. J

“…M cells in Peyer's patch epithelium conduct transepithelial transport of luminal antigens to cells of the mucosal immune system. To determine the distribution…”
Get full text

Changes in science and changing ideas about knowledge and authority in psychoanalysis by Mayer, E L

Get more information

Phase Ib dose-escalation trial of taselisib (GDC-0032) in combination with HER2-directed therapies in patients with advanced HER2+ breast cancer by Grinshpun, A., Ren, S., Graham, N., DeMeo, M.K., Wrabel, E., Carter, J., Tayob, N., Pereslete, A., Hamilton, E., Juric, D., Mayer, E.L., Tolaney, S.M., Krop, I.E., Metzger, O.

“…In most patients with advanced human epidermal growth factor receptor-2-positive (HER2+) breast cancer, anti-HER2 therapies fail due to the development of…”
Get full text

The phallic castration complex and primary femininity: paired developmental lines toward female gender identity by Mayer, E L

“…I suggest that two developmental lines contribute to the achievement of female gender identity. One is rooted in the phallic castration complex, and the other…”
Get more information